Growth and morbidity of infants are influenced by maternal milk oligosaccharides and infant gut microbiota

2 min read /
Gastroenterology Neonatology Paediatrics Gut health Healthy Eating & Hydration
Growth and morbidity of infants are influenced by maternal milk oligosaccharides and infant gut microbiota

Study findings showed longitudinal changes in human milk oligosaccharide (HMO) composition in human milk, as well as shifts in the infant’s gut microbiota were both associated with infant health outcomes. Specific HMOs may potentially lead to protection with lower rates of infection and/or inflammation, allowing the infant to invest energy in growth.

Save (for later)

These results suggest that specific types and structures of HMOs are sensitive to environmental conditions, protective of morbidity, predictive of growth, and correlated with specific microbiota.

Link to Publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227965/

Reference

Davis J, et al. Growth and morbidity of Gambian infants are influenced by maternal milk oligosaccharides and infant gut microbiota. Sci Rep. 2017; 40466.
 

If you liked this post you may also like

Factors Influenceing brain development in early life

Factors influencing brain development in early life

Co-Authored by 2 Experts
boy-with-brain

“The Learning Lead” - Volume 1 (2022)

boy-with-hair

[Science Update] Relationship between metabolites modulated by HMOs and reduced risk of LRTIs

Early-life gut ecology and reduced risk for reported LRTI

[Science Update] Early-life gut ecology and reduced risk for reported LRTI